Home / Inspections / 1147623

FDA Inspection 1147623 — Armstrong Pharmaceuticals, Inc.

Armstrong Pharmaceuticals, Inc. — FEI 3007009553

The FDA completed an inspection of Armstrong Pharmaceuticals, Inc. on July 14, 2021 in Canton, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 14, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Canton, MA (United States)

Facility

Other inspections at this facility

  • 1316472 (VAI Fri May 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1245297 (VAI Fri Jul 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 872285 (NAI Thu Apr 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 805461 (NAI Fri Oct 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 785248 (VAI Thu Jun 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources